Abstract
INTRODUCTION
Aplastic anemia (AA) is a commonly encountered hematological disease that presents with bone marrow failure and pancytopenia. 1 AA can be divided into acute AA and chronic AA (CAA), according to the development and severity of the disease. CAA characteristics include long disease course, predisposition to relapse and refractoriness, and poor quality of life; these are ascribed to the maintenance of drug therapy and the persistent risk of infection and bleeding. It is reported that the incidence of AA is 2/10 6 per year in western countries, while in China, the rate is nearly triple (~7. 4 / 10 6 ); CAA comprises almost 80% of these cases. 2 In Traditional Chinese Medicine (TCM), AA is called "Suilao", which means exhaustion of marrow. The application of TCM in the treatment of AA began 50 years ago. Before the 1980s, it was claimed that treatment of CAA should be based on "spleen (Pi)", and "fortify the spleen and replenish Qi" was emphasized, although limited effectiveness was achieved. After the 1980s, the consensus was that treatment of CAA should be based on "kidney reinforcing", and the method of "kidney warming and essence replenishing" was recommended. 3 To date, many studies have explored the mechanisms behind "kidney deficiency" in the development of AA, such as "Qi deficiency", "Yin deficiency", "blood stasis", and "stagnation of liver-Qi", 4 yet no consensus has been achieved, and the actual efficacy is not well established. In our center, we treat CAA with the unification of disease and syndrome differentiation. Reinforcing Qi and activating blood is highlighted, followed by kidney reinforcing. 5, 6 To clarify and compare the efficacy and advantages of modified TCM treatments based on kidney reinforcing with or without "Qi tonifying" or "blood activating", a multicenter randomized controlled trial was conducted.
MATERIALS AND METHODS

General data
From April 2010 to April 2012, 158 patients with CAA visited Zhejiang Provincial Hospital of Traditional Chinese Medicine, People's Hospital of Lishui, Tongde Hospital of Zhejiang Province, Taizhou Hospital of Zhejiang Province, and Jinhua Hospital of Traditional Chinese Medicine. One hundred and eleven of these patients were enrolled in this study (31 patients were excluded for not meeting the inclusion criteria, and the other 16 declined to receive TCM treatment). Simple randomization was used following a computer-generated random number sequence. Participants and practitioners were not blinded to allocation. All 111 patients were randomly divided into three groups of 37: kidney reinforcing alone (KA), kidney reinforcing and Qi tonifying (KQ), and kidney reinforcing and blood circulation invigorating (KC). Fifteen healthy people were enrolled in a normal control group, and another 16 patients without TCM treatment were enrolled as a positive control group. This study followed the Declaration of Helsinki and was approved by the Institution Committee of Ethics of Zhejiang Traditional Chinese Medicine Hospital. All the patients gave informed consent to treatment.
Diagnostic standards
Diagnostic standards in Western Medicine: AA was diagnosed according to the "Diagnosis and Treatment Standards of Hematology Disease (third edition)". 7 Patients with CAA present with: (a) slower progression than acute AA, and slight manifestation of anemia, infection and hemorrhage; (b) decreased hemoglobin, reticulocyte, neutrophil and platelet counts (but not to the same extent as that seen in acute AA); (c) decreased proliferation of two or three hematopoietic cell lines in the bone marrow, dysplasia at more than one site, significantly reduced numbers of megakaryocytes, and increased numbers of nonhematopoietic cells; and (d) a type of severe AA diagnosed upon confirmation of progressive disease. Kidney Yang deficiency syndrome differentiation in TCM: Patients presented with soreness and weakness in the waist and knees, cold body and limbs, pale complexion, poor appetite, diarrhea, plump tongue with whitish and slippery furring and bearing dental indentations on the margin, and a forceless deep pulse, which were diagnosed with kidney Yang deficiency according to "Guidelines for Diagnosis and Treatment of Common Internal Disease in Chinese Medicine". 
Therapies
, and the serum concentration was maintained at 150-250 ng/L. Supporting treatment: patients received erythrocyte suspension transfusion when hemoglobin was < 75 g/L or if they had significant symptoms of anemia even when hemoglobin was just below 80 g/L. Platelet transfusion and hemostatic treatment were administered when platelet count was < 5.0 × 10 9 /L (with no bleeding risk factor) or < 2.0 × 10 10 /L with bleeding risk factors. Anti-infective therapy was followed according to the site and severity of infection. Treatment period: each treatment course lasted 3 months, and two courses were followed.
Indexes and methods for observation
Common index: gender, age, body height and weight, vital signs, history of present illness, history of past illness, and frequency of blood transfusion in the last 3 months were recorded. Safety index: routine tests of blood, urine and stools, stool occult blood, abdominal ultrasound, electrocardiography, liver and renal function, and serum concentration of cyclosporine (if necessary) were assessed at the beginning and end of the trial. cyte monoclonal antibodies were purchased from BD Pharmingen (San Diego, CA, USA) and the human cytokine fluorescent reagent kits were purchased from Millipore (Boston, MA, USA). Side effect observation: commonly encountered side effects ascribe to the application of immune suppression and androgen, including gastrointestinal adverse reactions, secondary hypertension, polytrichia, gingival hyperplasia, rash, liver and renal dysfunction, and hand tremor, were observed.
Statistical analysis
The compiled data were first entered into an Excel spreadsheet, and then read into SPSS version 15.0 (SPSS, Chicago, IL, USA) biometric statistical software for further analysis. Normal data were expressed as the mean (standard deviation), and non-normal data were expressed as the median (interquartile range). Variance and pairwise comparisons were used for normal data, whereas non-normal data were subjected to nonparametric tests, wherein the Kruskal-Wallis H test was used for pairwise comparisons and the Mann-Whitney U test was used for multiple comparisons. P < 0.05 was considered statistically significant and P < 0.01 was considered statistically very significant.
RESULTS
Features of patients
During the observation (Figure 1) , 17 of 111 patients were withdrawn: four in the KA group; six in the KQ group; and seven in the KC group. Patients in the KA group (n = 33) were aged 15-60 years (median age 29.5 years), and included 12 men and 21 women. Patients in the KQ group (n = 31) were aged 16-67 years (median age 36.0 years), and included 11 men and 20 women. Patients in the KC group (n = 30) were aged 15-74 years (median age 35.5 years), and included eight men and 17 women. The positive control group (n = 16) was aged 17-59 years (median age 35.5 years), and included five men and 11 women. The normal control group (n = 15) was aged 24-50 years (median age 31.0 years), and included seven men and eight women. There was no significant difference in general data among the groups (P > 0.05) ( Table 1) .
Comparison of hemograms
There were no differences in the hemograms of patients in the four groups before treatment (P > 0.05). After 3 months, the WBC counts increased significantly only in the KQ group, from 2.9 ± 1.1×10 9 /L to 3.7 ± 1.7 × 10 9 /L (P < 0.05), which was higher than that in the positive control and KC groups (2.5 ± 1.0 × 10 9 /L and 2.6 ± 0.6 × 10 9 /L, respectively) (P < 0.05). The level of hemoglobin (Hb) increased in all three TCM groups combined (KA, KQ and KC) (P < 0.05), whereas in the KQ group, the difference was notable only when compared with Hb levels in the positive control group (P < 0.05). No differences were observed among all three TCM groups combined. Platelet counts did not increase in any group at the end of the first course of treatment. After 6 months, the increase in WBC count was still not obvious in all groups, except the KQ group (P < 0.05). The level of Hb increased in all groups (P < 0.05), and it was higher when compared with that 3 months ago only in the KQ group (P < 0.05). Platelet counts increased significantly only in the KC group when compared with counts before treatment. No differences were observed among the three TCM groups combined ( Table 2) .
Comparison of therapeutic effect in Western Medicine
After the first course of treatment (3 months), overall efficacy (OE) was 45.5% , 61.3% , 56.7% and 33.3% in the KA, KQ, KC and positive control groups, respectively. There was a significant difference between the KQ and positive control groups (P < 0.05). No differences were observed among the other groups. The OE was 69.7%, 77.4%, 80.0% and 50.0%, respectively, in the KA, KQ, KC and positive control groups after the second course of treatment (6 months), and there was improvement in the KA and KC groups when compared with 3 months previously (P < 0.05). The OE of the KC group was higher than that in the positive control group after 6 months' treatment (P < 0.05). No differences were observed among the three TCM groups combined (Table 3) . Notes: patients with chronic aplastic anemia (CAA) were randomly divided into three groups: "kidney reinforcing alone (KA)", "kidney reinforcing and Qi tonifying (KQ)" and "kidney reinforcing and blood circulation invigorating (KC)". Patients in the TCM treated groups were treated with modified "Yougui decoction", with the addition of kidney Yin tonifying herbs in KA group, Qi tonifying herbs in KQ group and blood circulation invigorating herbs in KC group. Normal and positive control groups were also formed. Patients in normal control group were treated without anything, and patients in positive control group were treated with western medicine alone (androgen with or without cyclosporine A for six months) respectively. All patients were treated for 6 months (two courses). The general data of the five groups were compared with each other. Data are shown as case (%), and no significant differences were observed. Notes: routine blood tests in the KA (kidney reinforcing alone), KQ (kidney reinforcing and Qi tonifying), KC (kidney reinforcing and blood circulation invigorating) and positive control groups were performed before treatment and 3 and 6 months after. Patients in the TCM treated groups were treated with modified "Yougui decoction", with the addition of kidney Yin tonifying herbs in KA group, Qi tonifying herbs in KQ group and blood circulation invigorating herbs in KC group. Patients in positive control group were treated with western medicine alone (androgen with or without cyclosporine A for six months). Hb: hemoglobin; PLT: platelet; WBC: white blood cell; TCM: Traditional Chinese Medicine. 
Comparison of TCM syndrome score
No differences were observed in the TCM syndrome score of each group (KA, KQ, KC and positive control groups) before treatment (12.2 ± 4.3, 11.9 ± 3.2, 11.7 ± 4.4 and 11.6 ± 4.7, respectively, P > 0.05). All the TCM groups combined (KA, KQ and KC) showed improvement in TCM syndrome when treated for 3 or 6 months. All syndrome scores decreased significantly (P < 0.01) and more obviously after 6 months (P < 0.05). In the positive control group, the score had a notable decrease only after the second course of treatment (6 months). Additionally, the score was lower in the KQ and KC groups when compared with that in the positive control group after 6 months (P < 0.05), while no differences were observed among the other groups (P > 0.05) (Table 4, Figure 2 ).
Comparison of therapeutic effect in TCM
OE was 57.6%, 67.7%, 60.0% and 50.0% in the KA, KQ, KC and positive control groups, respectively, after 3 months' treatment. After the second course of treatment (6 months), OE was 78.8%, 87.1%, 80.0% and 62.5% , respectively, in the four groups, and there was an improvement in the KQ group when compared with 3 months previously (P < 0.05). No significant differences were observed between the three TCM groups combined (Table 5) . 
Comparison of T-lymphocyte subsets and regulatory T cells
No differences in the ratio of T-lymphocyte subsets and regulatory T cells were observed among the three TCM groups combined and the positive control group. The ratio of CD3+ T lymphocytes decreased only in the KQ group after 6 months of treatment, while CD3 + CD4 + CD8 − T lymphocytes increased only in the KC group after 6 months of treatment (P < 0.05). All the TCM groups combined had a decreased level of CD3 + CD4 − CD8 + T lymphocytes (P < 0.01), while it increased in the positive control group after 6 months of treatment (P < 0.01). The CD3 + CD4 + CD25 + FoxP3+ regulatory T cell/CD3+CD4+ ratio decreased in all treated groups after 6 months, while no significant differences were observed ( Table 6 ).
Comparison of cytokines
Levels of IFN-γ, TNF-α, IL-2, IL-4, IL-6 and IL-10 were higher in patients with CAA when compared with those in the normal control group, while no significant differences were observed except for IL-2 and IL-4 levels (P < 0.05). Cytokine expression in all treatment groups did not show a significant change after 3 months (P > 0.05). After two courses of treatment (6 months), the levels of IFN-γ, TNF-α, IL-2 and IL-6 decreased, with further increases in IL-4 and IL-10 in all treated groups. IFN-γ, IL-2 and IL-6 levels in the TCM combined groups (KA, KQ and KC groups) were significantly lower than before treatment (P < 0.05 or P < 0.01), and IL-4 increased in all treated groups (P < 0.05). When compared with 3 months previously, IFN-γ, IL-2 and IL-6 in the KQ and KC groups and IL-4 in the KQ, KC and positive control groups had changed after 6 months (P < 0.05). In addition, the level of IL-6 in the KQ and KC groups after 6 months was lower than in the positive control group. No significant differences were observed between the three TCM groups combined ( Figure 2 TCM syndrome scores of the KA group, KQ group, KC group and the positive control group were evaluated before and 3 and 6 months after treatment Patients in the TCM treated groups were treated with modified "Yougui decoction", with the addition of kidney Yin tonifying herbs in KA group, Qi tonifying herbs in KQ group and blood circulation invigorating herbs in KC group. Patients in positive control group were treated with western medicine alone (androgen with or without cyclosporine A for six months). TCM: Traditional Chinese Medicine; KA: kidney reinforcing alone; KQ: kidney reinforcing and Qi tonifying; KC: kidney reinforcing. a P < 0.01, compared with that before treatment in the same group; b P < 0.05, compared with that at 3 months after treatment in the same group; c P < 0.05, compared with that in the positive control group at the same time. Notes: the therapeutic effects of TCM in the KA (kidney reinforcing alone), KQ (kidney reinforcing and Qi tonifying), KC (kidney reinforcing and blood circulation invigorating) and positive control groups were evaluated after treatment for 3 and 6 months. Patients in the TCM treated groups were treated with modified "Yougui decoction", with the addition of kidney Yin tonifying herbs in KA group, Qi tonifying herbs in KQ group and blood circulation invigorating herbs in KC group. Patients in positive control group were treated with western medicine alone (androgen with or without cyclosporine A for six months). TCM: Traditional Chinese Medicine. a P < 0.05, compared with that after 3 months' treatment in the same group; b P < 0.05, compared with that in the positive control group at the same time. 
Comparison of side effects
Incidence of gastrointestinal adverse reaction, polytrichia, gingival hyperplasia, and rash ranged from 37.5% to 62.5% in the positive control group. The incidence was higher than for other side effects: secondary hypertension 12.5% , liver dysfunction 18.75% , renal dysfunction 6.25% , and hand tremor 18.75% . With TCM treatment, the incidence of gastrointestinal adverse reaction, polytrichia, and rash decreased in the KA, KQ and KC groups (P < 0.01), and the development of liver dysfunction and hand tremor also decreased in the KC group (P < 0.05). No notable differences in the incidence of side effects were observed among the three TCM groups combined (Table 8) .
DISCUSSION
According to TCM, long-term disease is always accom- Table 7 Comparison of cytokines in different groups (pg/mL, x ± s) Notes: comparison of cytokines in the KA (kidney reinforcing alone), KQ (kidney reinforcing and Qi tonifying), KC (kidney reinforcing and blood circulation invigorating), positive control and normal control groups was performed before and 3 and 6 months after treatment. Patients in the TCM treated groups were treated with modified "Yougui decoction", with the addition of kidney Yin tonifying herbs in KA group, Qi tonifying herbs in KQ group and blood circulation invigorating herbs in KC group. Patients in positive control group were treated with western medicine alone (androgen with or without cyclosporine A for six months). IFN: interferon; IL: interleukin; TNF: tumor necrosis factor; TCM: Traditional Chinese Medicine. a P < 0.05, d P < 0.01, compared with that before treatment in the same group; b P < 0.05, compared with that after 3 months' treatment in the same group; c P < 0.05, compared with that in the normal control group; e P < 0.05, compared with that in the positive control group at the same time.
panied by deficiency syndrome and stasis syndrome, which challenges the therapeutic effects of treatment. Qi works with the assistance of Yang; CAA patients with kidney Yang deficiency also suffer from Qi deficiency. 9 Attributed to the stasis of blood in marrow, the production of "fresh blood" is always impaired as well. Besides kidney reinforcing, Qi tonifying and blood activating have already been applied in clinical practice, 10, 11 while no control study has been conducted and no further mechanism explored. We found that improvement of WBC and Hb counts was quicker in the KQ group than the KA and KC groups combined when compared with the positive control group, while platelet count only increased in the KC group. The recovery of hemograms was consistent with the therapeutic effect in Western Medicine. Patients in the KQ group had a 61.3% OE in 3 months, which was higher than in the positive control group (33.3% , P < 0.05). After 6 months, all groups showed improved OE, while only in the KC group, the index was significantly higher than in the positive control group (80% vs 50% , P < 0.05). In addition, the TCM syndrome scores in the KQ and KC groups also decreased significantly when compared with the positive control group after 6 months, while the therapeutic effect in TCM improved significantly only in the KQ group. Our results showed that the treatment based on kidney reinforcing and Qi tonifying achieved a quicker and greater therapeutic effect in CAA, although no differences were observed among the different TCM groups combined. The treatment based on kidney reinforcing and blood circulation invigorating may have a better effect on platelet recovery when compared with other TCM groups. It is confirmed that immune disorders play a crucial role in the onset and development of AA. The imbalance between cytotoxic and T helper (Th) cells leads to hyperactivity of cytotoxic T cells, which secrete cytokines that inhibit the process of hematopoiesis and induce apoptosis of stem cells, such as TNF-α and IFN-γ. 12, 13 According to TCM theory, we know that with "vital Qi" inside, no "evil" comes near. Treatment by strengthening vital Qi may work by modulating the immune function, which may also favor recovery from CAA. The results showed that the treatment based on TCM had a better effect on decreasing the ratio of cytotoxic T cells than the positive control group (P < 0.01), and KC may have had an advantage in increasing the ratio of Th cells (P < 0.05). The regulation of T cells may not be the therapeutic target of TCM in CAA, for no prominent differences were observed among the groups after 6 months. In our study, patients with CAA had significantly higher levels of IL-2 and IL-4 when compared with those in the normal control group. IL-2 is secreted by CD4+ Th1 cells, which may promote the proliferation of cytotoxic T cells, while IL-4 is secreted by CD4+ Th2 cells and causes downregulation. 14 Increases in IL-4 levels may be the inverse feedback of the body to stop the excursion of Th1 cells in CAA. TCM had a role in decreasing the levels of IFN-γ, IL-2 and IL-6, as well as promoting secretion of IL-4 (P < 0.05), which had a positive correlation with the treatment course. IL-6 decreased significantly in the KQ and KC groups when compared with the positive control group, indicating that IL-6 may be the target of KQ and KC in the treatment of CAA. Gastrointestinal adverse reaction, polytrichia, gingival hyperplasia, and rash are the most common side effects of taking cyclosporine or androgens, which are also the factors that affect patient compliance in clinical practice. 15, 16 Our study indicated that the treatment of TCM had a role in decreasing the incidence of gastrointestinal adverse reaction, polytrichia, and rash, and treatment with kidney reinforcing and blood circulation invigorating may also contribute to the reduction of liver dysfunction and hand tremor. 
